Prada is evaluating a potential acquisition of Versace from Capri Holdings, with Citi acting as its adviser. Capri Holdings has engaged Barclays to identify potential buyers for Versace, attracting interest from private equity funds and other fashion groups. This...
Northleaf Capital Partners has announced that its managed funds have completed an investment in CCM Hockey. The transaction was executed in partnership with Altor Equity Partners, a prominent European private equity firm specializing in middle-market investments. CCM...
Global healthcare private equity reached an estimated $115bn in 2024, marking the second-highest annual deal value on record, driven by a rise in large-scale transactions. The year saw five deals exceeding $5bn, up from two in 2023 and one in 2022. North America led...
The Vistria Group has closed its largest private equity fund to date, Vistria Fund V, with $3bn in total capital commitments. The firm now manages nearly $16bn across its funds and co-investment vehicles, more than doubling its assets under management in just over...
Aviceda Therapeutics has launched biotech financing in 2025 with a $207.5m raise to advance its lead drug for geographic atrophy, a sight-threatening disease, into pivotal trials. The Series C round, co-led by Omega Funds and TCGX, will support the ongoing phase 2/3... 